TriangleNCT05831787 · OUTCOME
COVID Booster Incidence
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- COUNT_OF_PARTICIPANTS
- Unit
- Participants
- Interval / dispersion
- Not reported
- Time frame
- 30 Days after enrollment
What was measured
Percent of patients who enroll on the study platform who went on to receive a SARS-CoV-2 booster at 1 month follow up visit
Analysis population: The total enrollment for the study was 201 patients. Although the initial enrollment goal was 200 patients, an additional participant consented before the study was closed to enrollment. However, this participant did not complete any study procedures. Four additional patients either withdrew or did not provide a response for this data variable.
Groups in this outcome
Diagnosis of Multiple Myeloma and Currently Receiving Active Treatment for Any Phase of the Disease
Diagnosis of multiple myeloma must meet the International Myeloma Working Group criteria. Patient Reported Outcomes: Patients will be asked to complete baseline, 30-day, and 6-month clinical and patient reported outcome health surveys.
| Group | Source count |
|---|---|
| Diagnosis of Multiple Myeloma and Currently Receiving Active Treatment for Any Phase of the Disease | 196 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Diagnosis of Multiple Myeloma and Currently Receiving Active Treatment for Any Phase of the Disease | 18 | Not reported | Not reported | Not reported | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- value
- 18
- denoms
- counts
- group Id
- OG000
- value
- 196
- units
- Participants
- description
- Percent of patients who enroll on the study platform who went on to receive a SARS-CoV-2 booster at 1 month follow up visit
- groups
- description
- Diagnosis of multiple myeloma must meet the International Myeloma Working Group criteria. Patient Reported Outcomes: Patients will be asked to complete baseline, 30-day, and 6-month clinical and patient reported outcome health surveys.
- id
- OG000
- title
- Diagnosis of Multiple Myeloma and Currently Receiving Active Treatment for Any Phase of the Disease
- param Type
- COUNT_OF_PARTICIPANTS
- population Description
- The total enrollment for the study was 201 patients. Although the initial enrollment goal was 200 patients, an additional participant consented before the study was closed to enrollment. However, this participant did not complete any study procedures. Four additional patients either withdrew or did not provide a response for this data variable.
- reporting Status
- POSTED
- time Frame
- 30 Days after enrollment
- title
- COVID Booster Incidence
- type
- SECONDARY
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice